VNRX
AMEX VolitionRX Ltd$0.1663 ↓ -0.0001 (-0.06%) Trading Down from the previous close of $0.1664, $0.0063 below the day’s high of $0.1726
- YTD change
- -96.75%
- vs 20-day SMA
- -24.45%
- vs 200-day SMA
- -93.09%
Price ranges
Price & Performance
+0.02 (+10.32%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $136.8000
- VNRX is down 97% since the beginning of the year
- VNRX is down 98% over the past 12 months
- VNRX is down 37% over the past 1 month
- 5% of all VNRX investors are betting against VNRX
- Number of investors short VNRX has gone down 75% versus last month
VNRX reads poor: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -59.7%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -9.96%
- vs 8-day SMA
- -10.93%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
